Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, p. annrheumdis-2021-220164, 2021
DOI: 10.1136/annrheumdis-2021-220164
BMJ Publishing Group, Annals of the Rheumatic Diseases, p. annrheumdis-2021-220001, 2021
DOI: 10.1136/annrheumdis-2021-220001
Links
Tools
Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles
Journal article published in 2021 by
Sofia Ramiro 
,
Rémy L. M. Mostard,
Robert B. M. Landewé ,
Josef S. Smolen
,
Rémy L. M. Mostard,
Robert B. M. Landewé ,
Josef S. Smolen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 